dbPTM

VIR_HUMAN - PTM Information in dbPTM

Basic Information of Protein

Overview of Protein Modification Sites with Functional and Structural Information
UniProt ID	VIR_HUMAN
UniProt AC	Q69YN4
Protein Name	Protein virilizer homolog {ECO:0000305}
Gene Name	VIRMA {ECO:0000312\|HGNC:HGNC:24500}
Organism	Homo sapiens (Human).
Sequence Length	1812
Subcellular Localization	Nucleus speckle . Nucleus, nucleoplasm . Cytoplasm . Mainly nuclear with some fraction located in the cytoplasm. ZC3H13 is required to anchor component of the MACOM subcomplex, such as VIRMA, in the nucleus.
Protein Description	Associated component of the WMM complex, a complex that mediates N6-methyladenosine (m6A) methylation of RNAs, a modification that plays a role in the efficiency of mRNA splicing and RNA processing. [PubMed: 24981863]
Protein Sequence	MAVDSAMELLFLDTFKHPSAEQSSHIDVVRFPCVVYINEVRVIPPGVRAHSSLPDNRAYGETSPHTFQLDLFFNNVSKPSAPVFDRLGSLEYDENTSIIFRPNSKVNTDGLVLRGWYNCLTLAIYGSVDRVISHDRDSPPPPPPPPPPPQPQPSLKRNPKHADGEKEDQFNGSPPRPQPRGPRTPPGPPPPDDDEDDPVPLPVSGDKEEDAPHREDYFEPISPDRNSVPQEGQYSDEGEVEEEQQEEGEEDEDDVDVEEEEDEDEDDRRTVDSIPEEEEEDEEEEGEEDEEGEGDDGYEQISSDEDGIADLERETFKYPNFDVEYTAEDLASVPPMTYDPYDRELVPLLYFSCPYKTTFEIEISRMKDQGPDKENSGAIEASVKLTELLDLYREDRGAKWVTALEEIPSLIIKGLSYLQLKNTKQDSLGQLVDWTMQALNLQVALRQPIALNVRQLKAGTKLVSSLAECGAQGVTGLLQAGVISGLFELLFADHVSSSLKLNAFKALDSVISMTEGMEAFLRGRQNEKSGYQKLLELILLDQTVRVVTAGSAILQKCHFYEVLSEIKRLGDHLAEKTSSLPNHSEPDHDTDAGLERTNPEYENEVEASMDMDLLESSNISEGEIERLINLLEEVFHLMETAPHTMIQQPVKSFPTMARITGPPERDDPYPVLFRYLHSHHFLELVTLLLSIPVTSAHPGVLQATKDVLKFLAQSQKGLLFFMSEYEATNLLIRALCHFYDQDEEEGLQSDGVIDDAFALWLQDSTQTLQCITELFSHFQRCTASEETDHSDLLGTLHNLYLITFNPVGRSAVGHVFSLEKNLQSLITLMEYYSKEALGDSKSKKSVAYNYACILILVVVQSSSDVQMLEQHAASLLKLCKADENNAKLQELGKWLEPLKNLRFEINCIPNLIEYVKQNIDNLMTPEGVGLTTALRVLCNVACPPPPVEGQQKDLKWNLAVIQLFSAEGMDTFIRVLQKLNSILTQPWRLHVNMGTTLHRVTTISMARCTLTLLKTMLTELLRGGSFEFKDMRVPSALVTLHMLLCSIPLSGRLDSDEQKIQNDIIDILLTFTQGVNEKLTISEETLANNTWSLMLKEVLSSILKVPEGFFSGLILLSELLPLPLPMQTTQVIEPHDISVALNTRKLWSMHLHVQAKLLQEIVRSFSGTTCQPIQHMLRRICVQLCDLASPTALLIMRTVLDLIVEDLQSTSEDKEKQYTSQTTRLLALLDALASHKACKLAILHLINGTIKGDERYAEIFQDLLALVRSPGDSVIRQQCVEYVTSILQSLCDQDIALILPSSSEGSISELEQLSNSLPNKELMTSICDCLLATLANSESSYNCLLTCVRTMMFLAEHDYGLFHLKSSLRKNSSALHSLLKRVVSTFSKDTGELASSFLEFMRQILNSDTIGCCGDDNGLMEVEGAHTSRTMSINAAELKQLLQSKEESPENLFLELEKLVLEHSKDDDNLDSLLDSVVGLKQMLESSGDPLPLSDQDVEPVLSAPESLQNLFNNRTAYVLADVMDDQLKSMWFTPFQAEEIDTDLDLVKVDLIELSEKCCSDFDLHSELERSFLSEPSSPGRTKTTKGFKLGKHKHETFITSSGKSEYIEPAKRAHVVPPPRGRGRGGFGQGIRPHDIFRQRKQNTSRPPSMHVDDFVAAESKEVVPQDGIPPPKRPLKVSQKISSRGGFSGNRGGRGAFHSQNRFFTPPASKGNYSRREGTRGSSWSAQNTPRGNYNESRGGQSNFNRGPLPPLRPLSSTGYRPSPRDRASRGRGGLGPSWASANSGSGGSRGKFVSGGSGRGRHVRSFTR

Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations	Modification	Substrate Peptides & Secondary Structure	ASA (%)	Reference
2	Acetylation	------MAVDSAMEL ------CCHHHHHHH	25.73	19413330
5	Phosphorylation	---MAVDSAMELLFL ---CCHHHHHHHHHH	23.94	26852163
14	Phosphorylation	MELLFLDTFKHPSAE HHHHHHHCCCCCCHH	36.41	26852163
16	Ubiquitination	LLFLDTFKHPSAEQS HHHHHCCCCCCHHHC	57.61	33845483
36	Phosphorylation	VRFPCVVYINEVRVI EEECEEEEECEEEEC	4.24	19664994
36 (in isoform 1)	Phosphorylation	-	4.24	-
38	Ubiquitination	FPCVVYINEVRVIPP ECEEEEECEEEECCC	24.83	22817900
59	Phosphorylation	SLPDNRAYGETSPHT CCCCCCCCCCCCCCE	16.56	22617229
62	Phosphorylation	DNRAYGETSPHTFQL CCCCCCCCCCCEEEE	43.10	28450419
63	Phosphorylation	NRAYGETSPHTFQLD CCCCCCCCCCEEEEE	15.47	28450419
64	Ubiquitination	RAYGETSPHTFQLDL CCCCCCCCCEEEEEE	37.65	23503661
66	Phosphorylation	YGETSPHTFQLDLFF CCCCCCCEEEEEEEE	19.23	28450419
89	Phosphorylation	PVFDRLGSLEYDENT CCCCCCCCEECCCCC	23.71	-
97	Phosphorylation	LEYDENTSIIFRPNS EECCCCCEEEECCCC	25.85	-
104	Phosphorylation	SIIFRPNSKVNTDGL EEEECCCCCCCCCCE	40.43	20068231
105	Ubiquitination	IIFRPNSKVNTDGLV EEECCCCCCCCCCEE	46.26	21906983
105 (in isoform 2)	Ubiquitination	-	46.26	21890473
105 (in isoform 1)	Ubiquitination	-	46.26	21890473
105 (in isoform 3)	Ubiquitination	-	46.26	21890473
105 (in isoform 4)	Ubiquitination	-	46.26	21890473
108	Phosphorylation	RPNSKVNTDGLVLRG CCCCCCCCCCEEECH	34.14	20068231
108 (in isoform 1)	Phosphorylation	-	34.14	-
133	Phosphorylation	GSVDRVISHDRDSPP CCCCCHHCCCCCCCC	19.24	29255136
133 (in isoform 1)	Phosphorylation	-	19.24	-
138	Phosphorylation	VISHDRDSPPPPPPP HHCCCCCCCCCCCCC	39.95	29255136
138 (in isoform 1)	Phosphorylation	-	39.95	-
154	Phosphorylation	PPPQPQPSLKRNPKH CCCCCCCCCCCCCCC	41.07	23927012
166	Acetylation	PKHADGEKEDQFNGS CCCCCCCCCCCCCCC	72.60	91089
173	Phosphorylation	KEDQFNGSPPRPQPR CCCCCCCCCCCCCCC	32.60	29255136
173 (in isoform 1)	Phosphorylation	-	32.60	-
184	Phosphorylation	PQPRGPRTPPGPPPP CCCCCCCCCCCCCCC	36.65	29255136
184 (in isoform 1)	Phosphorylation	-	36.65	-
193	Ubiquitination	PGPPPPDDDEDDPVP CCCCCCCCCCCCCCC	67.96	27667366
204	Phosphorylation	DPVPLPVSGDKEEDA CCCCCCCCCCCCCCC	39.06	23927012
217	Phosphorylation	DAPHREDYFEPISPD CCCCCCCCCCCCCCC	12.70	23927012
222	Phosphorylation	EDYFEPISPDRNSVP CCCCCCCCCCCCCCC	31.31	19664994
222 (in isoform 1)	Phosphorylation	-	31.31	-
235	Phosphorylation	VPQEGQYSDEGEVEE CCCCCCCCCCCCCCH	22.69	18452278
235 (in isoform 1)	Phosphorylation	-	22.69	-
241	Ubiquitination	YSDEGEVEEEQQEEG CCCCCCCCHHHHHCC	52.06	21963094
302	Phosphorylation	DDGYEQISSDEDGIA CCCCHHCCCCCCCHH	31.28	18452278
302 (in isoform 1)	Phosphorylation	-	31.28	-
303	Phosphorylation	DGYEQISSDEDGIAD CCCHHCCCCCCCHHH	46.80	18452278
303 (in isoform 1)	Phosphorylation	-	46.80	-
315	Phosphorylation	IADLERETFKYPNFD HHHHHHHHCCCCCCC	31.48	28787133
355	Phosphorylation	LLYFSCPYKTTFEIE EEEEECCCCEEEEEE	25.87	-
357	Phosphorylation	YFSCPYKTTFEIEIS EEECCCCEEEEEEEE	30.76	-
367	Ubiquitination	EIEISRMKDQGPDKE EEEEECCHHCCCCCC	45.87	-
373	Ubiquitination	MKDQGPDKENSGAIE CHHCCCCCCCCCHHH	63.03	21906983
373	Acetylation	MKDQGPDKENSGAIE CHHCCCCCCCCCHHH	63.03	25953088
373 (in isoform 1)	Ubiquitination	-	63.03	21890473
373 (in isoform 2)	Ubiquitination	-	63.03	21890473
373 (in isoform 3)	Ubiquitination	-	63.03	21890473
373 (in isoform 4)	Ubiquitination	-	63.03	21890473
399	Ubiquitination	YREDRGAKWVTALEE HHHCCCCCHHHHHHH	45.05	23503661
399 (in isoform 2)	Ubiquitination	-	45.05	-
402	Phosphorylation	DRGAKWVTALEEIPS CCCCCHHHHHHHCHH	25.14	20068231
409	Phosphorylation	TALEEIPSLIIKGLS HHHHHCHHHHHHHCC	37.55	20068231
416	Phosphorylation	SLIIKGLSYLQLKNT HHHHHHCCCEEECCC	32.25	-
506	Ubiquitination	LKLNAFKALDSVISM CCHHHHHHHHHHHHH	15.33	27667366
528	Ubiquitination	LRGRQNEKSGYQKLL HHHCCCCCCHHHHHH	57.65	27667366
552	Ubiquitination	RVVTAGSAILQKCHF EEEECCHHHHHHCCH	12.95	22817900
556	Ubiquitination	AGSAILQKCHFYEVL CCHHHHHHCCHHHHH	26.65	-
558	Ubiquitination	SAILQKCHFYEVLSE HHHHHHCCHHHHHHH	35.05	21963094
564	Ubiquitination	CHFYEVLSEIKRLGD CCHHHHHHHHHHHHH	42.31	21890473
576	Ubiquitination	LGDHLAEKTSSLPNH HHHHHHHHCCCCCCC	48.37	21906983
576 (in isoform 2)	Ubiquitination	-	48.37	21890473
576 (in isoform 1)	Ubiquitination	-	48.37	21890473
576 (in isoform 3)	Ubiquitination	-	48.37	21890473
576 (in isoform 4)	Ubiquitination	-	48.37	21890473
584	Phosphorylation	TSSLPNHSEPDHDTD CCCCCCCCCCCCCCC	58.42	25849741
590	Phosphorylation	HSEPDHDTDAGLERT CCCCCCCCCCCCCCC	25.08	-
660	Phosphorylation	FPTMARITGPPERDD CCCCCCCCCCCCCCC	37.77	21712546
694	Ubiquitination	LLLSIPVTSAHPGVL HHHHCCCCCCCCCHH	18.16	22817900
841	Ubiquitination	KEALGDSKSKKSVAY HHHHCCCCCCHHHHH	71.66	27667366
843	Acetylation	ALGDSKSKKSVAYNY HHCCCCCCHHHHHHH	53.45	7707055
874	Phosphorylation	MLEQHAASLLKLCKA HHHHHHHHHHHHHHC	34.71	24719451
880	Ubiquitination	ASLLKLCKADENNAK HHHHHHHHCCCCCHH	70.12	33845483
887	Ubiquitination	KADENNAKLQELGKW HCCCCCHHHHHHHHH	53.48	21906983
887	Acetylation	KADENNAKLQELGKW HCCCCCHHHHHHHHH	53.48	25953088
887 (in isoform 1)	Ubiquitination	-	53.48	21890473
887 (in isoform 2)	Ubiquitination	-	53.48	21890473
887 (in isoform 3)	Ubiquitination	-	53.48	21890473
887 (in isoform 4)	Ubiquitination	-	53.48	21890473
893	Ubiquitination	AKLQELGKWLEPLKN HHHHHHHHHHHHHHH	62.32	21963094
899	Ubiquitination	GKWLEPLKNLRFEIN HHHHHHHHHCCEEEE	65.73	21890473
899 (in isoform 1)	Ubiquitination	-	65.73	21890473
899 (in isoform 2)	Ubiquitination	-	65.73	21890473
899 (in isoform 3)	Ubiquitination	-	65.73	21890473
899 (in isoform 4)	Ubiquitination	-	65.73	21890473
914	Phosphorylation	CIPNLIEYVKQNIDN CHHHHHHHHHHHHHH	13.12	22817900
924	Phosphorylation	QNIDNLMTPEGVGLT HHHHHCCCCCCCCHH	22.73	-
981	Phosphorylation	RVLQKLNSILTQPWR HHHHHHHHHHHCCEE	29.43	20068231
1029	Ubiquitination	RGGSFEFKDMRVPSA CCCCCCCCCCCCCHH	43.34	22817900
1029 (in isoform 1)	Ubiquitination	-	43.34	21890473
1029 (in isoform 2)	Ubiquitination	-	43.34	21890473
1029 (in isoform 3)	Ubiquitination	-	43.34	21890473
1029 (in isoform 4)	Ubiquitination	-	43.34	21890473
1080	Phosphorylation	QGVNEKLTISEETLA CCCCCCCCCCHHHHH	33.26	-
1100	Phosphorylation	LMLKEVLSSILKVPE HHHHHHHHHHHCCCC	22.10	21406692
1101	Phosphorylation	MLKEVLSSILKVPEG HHHHHHHHHHCCCCC	27.98	24719451
1252	Ubiquitination	LINGTIKGDERYAEI HHCCCCCCCHHHHHH	37.85	27667366
1377	Phosphorylation	KNSSALHSLLKRVVS CCHHHHHHHHHHHHH	35.93	24719451
1380	Ubiquitination	SALHSLLKRVVSTFS HHHHHHHHHHHHHHC	48.73	29967540
1430	Phosphorylation	EGAHTSRTMSINAAE ECCCCCCCEECCHHH	18.29	23403867
1432	Phosphorylation	AHTSRTMSINAAELK CCCCCCEECCHHHHH	16.45	23403867
1444	Phosphorylation	ELKQLLQSKEESPEN HHHHHHHCCCCCCCH	41.84	23186163
1445	Ubiquitination	LKQLLQSKEESPENL HHHHHHCCCCCCCHH	53.17	29967540
1448	Phosphorylation	LLQSKEESPENLFLE HHHCCCCCCCHHHHH	38.31	27732954
1458	Ubiquitination	NLFLELEKLVLEHSK HHHHHHHHHHHHCCC	57.42	29967540
1464	Phosphorylation	EKLVLEHSKDDDNLD HHHHHHCCCCCCCHH	28.53	20068231
1465	Ubiquitination	KLVLEHSKDDDNLDS HHHHHCCCCCCCHHH	68.06	29967540
1472	Phosphorylation	KDDDNLDSLLDSVVG CCCCCHHHHHHHHHH	33.72	20068231
1476	Phosphorylation	NLDSLLDSVVGLKQM CHHHHHHHHHHHHHH	20.76	20068231
1494	Phosphorylation	SGDPLPLSDQDVEPV CCCCCCCCCCCCHHH	31.14	25332170
1503	Phosphorylation	QDVEPVLSAPESLQN CCCHHHHCCCHHHHH	41.85	25332170
1507	Phosphorylation	PVLSAPESLQNLFNN HHHCCCHHHHHHCCC	33.91	25332170
1518	Phosphorylation	LFNNRTAYVLADVMD HCCCCHHHHHHHHCC	8.72	20068231
1561	Phosphorylation	ELSEKCCSDFDLHSE HHHHHHCCCCCCCHH	51.27	27251275
1572	Phosphorylation	LHSELERSFLSEPSS CCHHHHHHHHCCCCC	22.59	23927012
1575	Phosphorylation	ELERSFLSEPSSPGR HHHHHHHCCCCCCCC	45.51	25463755
1578	Phosphorylation	RSFLSEPSSPGRTKT HHHHCCCCCCCCCCC	45.15	22167270
1579	Phosphorylation	SFLSEPSSPGRTKTT HHHCCCCCCCCCCCC	41.93	29255136
1583	Phosphorylation	EPSSPGRTKTTKGFK CCCCCCCCCCCCCEE	38.36	25159151
1587	Ubiquitination	PGRTKTTKGFKLGKH CCCCCCCCCEECCCC	68.53	27667366
1595	Ubiquitination	GFKLGKHKHETFITS CEECCCCCCCEEECC	46.77	29967540
1602	Phosphorylation	KHETFITSSGKSEYI CCCEEECCCCCCCCC	32.07	28555341
1603	Phosphorylation	HETFITSSGKSEYIE CCEEECCCCCCCCCC	41.40	25627689
1605	Acetylation	TFITSSGKSEYIEPA EEECCCCCCCCCCCC	41.90	26051181
1608	Phosphorylation	TSSGKSEYIEPAKRA CCCCCCCCCCCCCCC	20.06	28796482
1613	Ubiquitination	SEYIEPAKRAHVVPP CCCCCCCCCCCCCCC	61.91	33845483
1613	Acetylation	SEYIEPAKRAHVVPP CCCCCCCCCCCCCCC	61.91	25953088
1626	Methylation	PPPRGRGRGGFGQGI CCCCCCCCCCCCCCC	40.47	115481053
1634	Methylation	GGFGQGIRPHDIFRQ CCCCCCCCHHHHHHH	29.35	115481061
1646	Phosphorylation	FRQRKQNTSRPPSMH HHHHHCCCCCCCCCC	24.50	20068231
1647	Phosphorylation	RQRKQNTSRPPSMHV HHHHCCCCCCCCCCH	50.79	20068231
1651	Phosphorylation	QNTSRPPSMHVDDFV CCCCCCCCCCHHHHH	24.97	30576142
1663	Acetylation	DFVAAESKEVVPQDG HHHHHCCCCCCCCCC	46.14	7370215
1687	Dimethylation	VSQKISSRGGFSGNR CCHHHHHCCCCCCCC	42.32	-
1687	Methylation	VSQKISSRGGFSGNR CCHHHHHCCCCCCCC	42.32	24395707
1694	Dimethylation	RGGFSGNRGGRGAFH CCCCCCCCCCCCCCC	53.09	-
1694	Methylation	RGGFSGNRGGRGAFH CCCCCCCCCCCCCCC	53.09	24395717
1697	Dimethylation	FSGNRGGRGAFHSQN CCCCCCCCCCCCCCC	35.77	-
1697	Methylation	FSGNRGGRGAFHSQN CCCCCCCCCCCCCCC	35.77	54561481
1702	Phosphorylation	GGRGAFHSQNRFFTP CCCCCCCCCCCCCCC	23.77	28509920
1708	Phosphorylation	HSQNRFFTPPASKGN CCCCCCCCCCCCCCC	26.17	21712546
1712	Phosphorylation	RFFTPPASKGNYSRR CCCCCCCCCCCCCCC	47.04	20068231
1719	Methylation	SKGNYSRREGTRGSS CCCCCCCCCCCCCCC	40.53	115481077
1723	Dimethylation	YSRREGTRGSSWSAQ CCCCCCCCCCCCCCC	54.58	-
1723	Methylation	YSRREGTRGSSWSAQ CCCCCCCCCCCCCCC	54.58	24129315
1728	Phosphorylation	GTRGSSWSAQNTPRG CCCCCCCCCCCCCCC	23.17	22199227
1732	Phosphorylation	SSWSAQNTPRGNYNE CCCCCCCCCCCCCCC	11.41	21712546
1734	Methylation	WSAQNTPRGNYNESR CCCCCCCCCCCCCCC	43.90	115382751
1741	Asymmetric dimethylarginine	RGNYNESRGGQSNFN CCCCCCCCCCCCCCC	47.27	-
1741	Methylation	RGNYNESRGGQSNFN CCCCCCCCCCCCCCC	47.27	24395727
1749	Methylation	GGQSNFNRGPLPPLR CCCCCCCCCCCCCCC	43.92	115481045
1759	Phosphorylation	LPPLRPLSSTGYRPS CCCCCCCCCCCCCCC	28.65	26657352
1760	Phosphorylation	PPLRPLSSTGYRPSP CCCCCCCCCCCCCCH	33.27	28152594
1761	Phosphorylation	PLRPLSSTGYRPSPR CCCCCCCCCCCCCHH	34.55	28152594
1763	Phosphorylation	RPLSSTGYRPSPRDR CCCCCCCCCCCHHCC	21.31	26074081
1766	Phosphorylation	SSTGYRPSPRDRASR CCCCCCCCHHCCCCC	24.46	26055452
1773	Asymmetric dimethylarginine	SPRDRASRGRGGLGP CHHCCCCCCCCCCCC	37.53	-
1773	Methylation	SPRDRASRGRGGLGP CHHCCCCCCCCCCCC	37.53	24129315
1775	Asymmetric dimethylarginine	RDRASRGRGGLGPSW HCCCCCCCCCCCCCH	34.59	-
1775	Methylation	RDRASRGRGGLGPSW HCCCCCCCCCCCCCH	34.59	24129315
1793	Asymmetric dimethylarginine	NSGSGGSRGKFVSGG CCCCCCCCCCCCCCC	56.44	-
1793	Methylation	NSGSGGSRGKFVSGG CCCCCCCCCCCCCCC	56.44	24129315
1798	Phosphorylation	GSRGKFVSGGSGRGR CCCCCCCCCCCCCCC	40.34	20068231
1801	Phosphorylation	GKFVSGGSGRGRHVR CCCCCCCCCCCCCCC	28.92	20068231
1808	Methylation	SGRGRHVRSFTR--- CCCCCCCCCCCC---	21.67	54557005
1812	Methylation	RHVRSFTR------- CCCCCCCC-------	42.40	115481069

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)

Modified Location	Modified Residue	Modification	Type of Upstream Proteins	Gene Name of Upstream Proteins	UniProt AC of Upstream Proteins	Sources
Oops, there are no upstream regulatory protein records of VIR_HUMAN !!

Functions of PTM Sites

Modified Location	Modified Residue	Modification	Function	Reference
Oops, there are no descriptions of PTM sites of VIR_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location	Modification	Variant Position (Distance <= 10)	Residue Change	SAP	Related Disease	Reference
Oops, there are no SNP-PTM records of VIR_HUMAN !!

Protein-Protein Interaction

Interacting Protein	Gene Name	Interaction Type	PPI Reference	Domain-Domain Interactions
BPTF_HUMAN	BPTF	physical	26344197
ZC3HD_HUMAN	ZC3H13	physical	26344197

Drug and Disease Associations

Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.

Regulatory Network of VIR_HUMAN

Related Literatures of Post-Translational Modification

Acetylation
Reference	PubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-1579, AND MASS SPECTROMETRY.	19413330 [Abstract]
Phosphorylation
Reference	PubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-138 AND SER-1579, ANDMASS SPECTROMETRY.	19690332 [Abstract]
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-1579, AND MASS SPECTROMETRY.	19413330 [Abstract]
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1579 AND THR-1708, ANDMASS SPECTROMETRY.	18669648 [Abstract]
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1579, AND MASSSPECTROMETRY.	16964243 [Abstract]
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173; THR-184 ANDSER-222, AND MASS SPECTROMETRY.	17081983 [Abstract]
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-222 AND SER-1579, ANDMASS SPECTROMETRY.	15302935 [Abstract]